Activated protein C reduces tissue hypoxia, inflammation, and apoptosis in traumatized skeletal muscle during endotoxemia

被引:14
作者
Gierer, Philip [1 ]
Hoffmann, Johannes N.
Mahr, Felix
Menger, Michael D.
Mittlmeier, Thomas
Gradl, Georg
Vollmar, Brigitte
机构
[1] Univ Rostock, Inst Expt Surg, D-2500 Rostock 1, Germany
[2] Univ Rostock, Dept Trauma & Reconstruct Surg, D-2500 Rostock 1, Germany
[3] Univ Munich, Klinikum Grosshadern, Dept Surg, D-8000 Munich, Germany
[4] Univ Saarland, Inst Clin & Expt Surg, D-6650 Homburg, Germany
关键词
microcirculation; coagulation; lipopolysaccharide;
D O I
10.1097/01.CCM.0000275270.14835.2A
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: Extensive surgical trauma leads to activation of the coagulation cascade and is often complicated by systemic inflammation and infection. Activated protein C, a natural coagulatory inhibitor, was recently shown to reduce mortality in septic patients. We herein report on the actions of activated protein C on skeletal muscle injury in experimental endotoxemia. Design: Prospective controlled animal study. Setting: University animal research facility. Subjects: Male Sprague-Dawley rats. Interventions: Closed soft tissue trauma was applied on the left hind limb of pentobarbital-anesthetized rats. Six hours later endotoxemia was induced by intraperitoneal injection of Escherichia coli lipopolysaccharide. An equivalent volume of physiologic saline was given in controls. At the same time point, treatment of animals was started by continuous intravenous application of activated protein C (24 mu g/kg.hr) or vehicle solution over 18 hrs. Twenty-four hours after trauma, the extensor digitorum longus muscle was microsurgically exposed and analyzed by means of high-resolution multifluorescence microscopy. Measurements and Main Results: Endotoxemia aggravated traumatized muscle injury, as evidenced by reduced nutritive perfusion, increased tissue hypoxia, enhanced leukocyte-endothelial cell interaction, and apoptotic myocyte cells (249 +/- 17 cm/cm(2) vs. 298 +/- 22 cm/cm(2); reduced nicotinamide adenine dinucleotide [NADH], 149 +/- 15 arbitrary units [AU] vs. 130 +/- 13 AU; 417 +/- 79 cells/mm(2) vs. 344 +/- 77 cells/mm(2) and 62 +/- 9 cells/mm(2) vs. 31 +/- 5 cells/mm(2)). Therapeutic intervention with activated protein C 6 hrs after trama protected nutritive perfusion and tissue oxygenation (341 +/- 24 cm/cm(2) and 115 +/- 8 AU) and reduced inflammatory leukocyte adherence (185 +/- 60 cells/mm(2)) and cellular apoptosis (15 +/- 4 cells/mm(2)). Of note, the protection of traumatized muscle tissue by activated protein C was also maintained during endotoxemia, as indicated by a functional capillary density of 379 +/- 10 cm/cm(2), a NADH-fluorescence of 102 +/- 6 AU, a leukocyte adherence of 82 +/- 12 cells/mm(2), and a myocyte apoptosis of 28 +/- 4 cells/mm(2). Conclusions: Microcirculatory injury of traumatized skeletal muscle tissue is enhanced by intravenous endotoxin application in this model of soft tissue trauma. Activated protein C ameliorates microcirculatory dysfunction and tissue injury, in particular in traumatized animals during endotoxemia.
引用
收藏
页码:1966 / 1971
页数:6
相关论文
共 31 条
[1]   Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death [J].
Abraham, E ;
Laterre, P ;
Garg, R ;
Levy, H ;
Talwar, D ;
Trzaskoma, BL ;
Francois, B ;
Guy, JS ;
Bruckmann, M ;
Rea-Neto, A ;
Rossaint, R ;
Perrotin, D ;
Sablotzki, A ;
Arkins, N ;
Utterback, BG ;
Macias, WL .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) :1332-1341
[2]   Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care [J].
Angus, DC ;
Linde-Zwirble, WT ;
Lidicker, J ;
Clermont, G ;
Carcillo, J ;
Pinsky, MR .
CRITICAL CARE MEDICINE, 2001, 29 (07) :1303-1310
[3]   Benefit/risk profile of drotrecogin alfa (activated) in surgical patients with severe sepsis [J].
Barie, PS ;
Williams, MD ;
McCollam, JS ;
Bates, BM ;
Qualy, RL ;
Lowry, SF ;
Fry, DE .
AMERICAN JOURNAL OF SURGERY, 2004, 188 (03) :212-220
[4]   Drotrecogin alfa (activated) (recombinant human activated protein C) for the treatment of severe sepsis [J].
Bernard, GR .
CRITICAL CARE MEDICINE, 2003, 31 (01) :S85-S93
[5]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[6]   Influence of drotrecogin alpha (activated) infusion on the variation of Bax/Bcl-2 and Bax/Bcl-xl ratios in circulating mononuclear cells: A cohort study in septic shock patients [J].
Bilbault, Pascal ;
Lavaux, Thomas ;
Launoy, Anne ;
Gaub, Marie P. ;
Meyer, Nicolas ;
Oudet, Pierre ;
Pottecher, Thierry ;
Jaeger, Albert ;
Schneider, Francis .
CRITICAL CARE MEDICINE, 2007, 35 (01) :69-75
[7]   Effects of drotrecogin alfa activated on micro circulatory alterations in patients with severe sepsis [J].
de Backer, Daniel ;
Verdant, Colin ;
Chierego, Marialuisa ;
Koch, Marc ;
Gullo, Antonino ;
Vincent, Jean-Louis .
CRITICAL CARE MEDICINE, 2006, 34 (07) :1918-1924
[8]   Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock [J].
Dellinger, RP ;
Carlet, JM ;
Masur, H ;
Gerlach, H ;
Calandra, T ;
Cohen, J ;
Gea-Banacloche, J ;
Keh, D ;
Marshall, JC ;
Parker, MM ;
Ramsay, G ;
Zimmerman, JL ;
Vincent, JL ;
Levy, MM .
CRITICAL CARE MEDICINE, 2004, 32 (03) :858-873
[9]  
DIXON CE, 1991, J NEUROSCI METH, V39, P253
[10]   Selective cyclooxygenase-2 inhibition reverses microcirculatory and inflammatory sequelae of closed soft-tissue trauma in an animal model [J].
Gierer, P ;
Mittlmeier, T ;
Bordel, R ;
Schaser, KD ;
Gradl, G ;
Vollmar, B .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2005, 87A (01) :153-160